Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares U.S. Healthcare ETF (NY: IYH )

59.05 +0.24 (+0.41%)
Official Closing Price Updated: 5:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 287,923
Open 58.83
Bid (Size) 57.86 (35)
Ask (Size) 60.16 (33)
Prev. Close 58.81
Today's Range 58.56 - 59.05
52wk Range 56.60 - 66.59
Shares Outstanding 523,500
Dividend Yield 1.59%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252%
Billionaire Stanley Druckenmiller's latest large wager on biotech company Natera Inc has paid off, with his stake now exceeding $575 million. 
Via Benzinga
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga

Performance

YTD
+1.55%
+1.55%
1 Month
-3.67%
-3.67%
3 Month
-9.68%
-9.68%
6 Month
-4.11%
-4.11%
1 Year
+3.90%
+3.90%

More News

Read More
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Via Benzinga
Topics ETFs
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
Via Benzinga
Topics Government
Exposures Political Product Safety
What Lies In Store For Healthcare ETFs In Q3 Earnings?
Via Talk Markets
Topics ETFs
Deere, Amgen, Copart And More: CNBC's 'Final Trades'
Via Benzinga
Defensive ETFs Shine Amid A Rough Start To September
Via Talk Markets
Topics ETFs
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
Via Benzinga
Delta Air Lines, Interactive Brokers And More: CNBC's 'Final Trades'
Via Benzinga
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Via Benzinga
Topics Government
Exposures Political
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
Via The Motley Fool
'Barbarism:' AOC Unleashes Fury On US Healthcare System As People Are 'Choosing Between Medicine And Rent'
Via Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Via Talk Markets
Topics ETFs
Target, Apollo Global Management, Las Vegas Sands And More: CNBC's 'Final Trades'
Via Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
Via Benzinga
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
Via Benzinga
Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
Via Benzinga
Humana, Comerica, Cleveland-Cliffs, And More: CNBC's 'Final Trades'
Via Benzinga
Cisco, Burlington Stores, Broadcom And More On CNBC's 'Final Trades'
Via Benzinga
Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
Via Benzinga
Exposures Product Safety
All eyes on the Fed as inflation metrics give mixed signals
Via Talk Markets
Topics Economy
Exposures Interest Rates
Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout
Via Benzinga
4 Top-Ranked Sector ETFs To Buy In The Second Half
Via Talk Markets
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Via Benzinga
The 3 Most Promising Industries to Invest in for 2023’s Second Half
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.